Cancer patients in England are experiencing prolonged waits for treatment despite government targets aimed at improving care. A 70-year-old patient identified as Alan waited approximately 128 days for lung cancer surgery after being diagnosed in June of the previous year, during which time his cancer spread to his lymph nodes and progressed significantly. The delay resulted in more complex surgery and lasting complications for the patient.
The government established ambitions through its National Cancer Plan and NHS Planning Guidance to have 80% of patients begin treatment within 62 days from urgent GP referral by March 2027, escalating to 85% by March 2029. However, recent data indicates performance has declined rather than improved. Currently, 71.2% of patients start cancer treatment within the 62-day window, down from the previous figure of 71.9%. According to NHS data released for July, only 10 out of 120 hospital trusts in England achieved the 85% treatment initiation target. Analysis by Radiotherapy UK suggests that more than 2,800 additional patients would need to begin treatment monthly—a near 15% increase from current volumes—to meet the March 2027 target.
Leading oncologist Pat Price has characterized the government targets as “now simply impossible to hit” due to a “complete loss of momentum” and attributed current failures to insufficient planning and accountability structures. The plan called for establishing an independent cancer board, though leadership for this group remains undetermined. Medical evidence indicates that for every month a cancer patient delays treatment initiation, their survival probability declines by approximately 10% on average. To achieve its 2029 goal, roughly 54,000 additional patients will need to begin treatment within the 62-day period.
Salisbury NHS Trust has demonstrated some progress through focused operational improvements, including enhanced appointment tracking and support systems. The trust has achieved notable advances in skin and prostate cancer treatment pathways. However, systemic challenges persist across multiple hospital trusts, including workforce shortages, diagnostic bottlenecks, equipment failures and maintenance issues, rising patient demand, and missed appointments. Trusts reporting the sharpest performance declines cited industrial action, staff shortages, and diagnostic provider limitations as contributing factors. Advocacy organizations have called for governments to align resources and urgency with stated ambitions for improving cancer treatment delivery.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI